NACL Industries Limited has informed the Exchange regarding allotment of 32501851 securities pursuant to Rights Issue at its meeting held on December 31, 2025

Corporate Actions View source PDF Explain this filing

NACLIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.2%Reaction day

₹164.99

prior close

₹165.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+4.0% vs market

Pesticides & Agrochemicals peers, median of 27sector+0.0%+4.2% vs sector

On the reaction day the stock moved 4.0 pts more than Nifty Microcap 250 and 4.2 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.8

10m

-0.8

15m

-0.3

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.2+0.2+4.0+0.0+4.2

Next day

+1.8+1.1+0.7+0.3+1.5

+3.6+1.4+2.2-0.2+3.8

+9.1+0.7+8.4-1.6+10.7

+14.6+0.7+13.9-1.6+16.2

+8.9-1.2+10.1-1.8+10.7

+2.1-3.7+5.9-5.6+7.7

15d

-3.6-9.0+5.3-10.2+6.5

-18.8-6.8-11.9-7.0-11.8

-23.0-7.6-15.4-11.8-11.2

-20.2-12.3-7.9-19.5-0.8

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NACL Industries has completed its rights issue by allotting 3.25 crore equity shares (face value ₹1 each) at ₹76.70 per share on December 31, 2025, raising approximately ₹249.3 crore. The paid-up equity share capital has risen from ₹20.15 crore to ₹23.40 crore, a dilution of about 16% in the share base. The Letter of Offer was issued on December 8, 2025 at a premium of ₹75.70 per share. Additionally, the company is investing ₹83 crore in its wholly owned subsidiary NACL Spec-Chem Limited through 8,300 Compulsorily Convertible Debentures of ₹1 lakh each, to be used by the subsidiary for repaying its existing loans.

Likely market impact

Existing shareholders face meaningful share dilution (~16%) while the company strengthens its balance sheet with ~₹249 crore in fresh equity. The ₹83 crore deployment into the subsidiary is for debt repayment rather than growth, which may be neutral to mildly positive if it lowers consolidated interest costs.